Immune, Gene and Cell Therapy
7.5 credits
Course, Master's level, 3MG018
Expand the information below to show details on how to apply and entry requirements.
Autumn 2026 Autumn 2026, Uppsala, 50%, On-campus, English
- Location
- Uppsala
- Pace of study
- 50%
- Teaching form
- On-campus
- Instructional time
- Evening
- Study period
- 14 September 2026–29 November 2026
- Language of instruction
- English
- Entry requirements
-
120 credits in medicine, biomedicine, biology, pharmacy or biomedical laboratory science
- Selection
-
Higher education credits in science and engineering (maximum 240 credits)
- Fees
- If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 20,625
- Total tuition fee: SEK 20,625
- Application deadline
- 15 April 2026
- Application code
- UU-42007
Admitted or on the waiting list?
About the course
The course gives an overview of new and established treatments based on immune, gene and cell therapy. The course will discuss new opportunities as well as difficulties with these kinds of therapies. Some areas that will be at focus are transplantation of endocrine cells, immunotherapy of cancer and stem cell transplantation.
The course is a seminar series consisting of ten meetings. The seminars will be held by scientists and/or medical doctors in the field.